KAYS (Kaya Holdings) Debt-to-Asset : 33.70 (As of Sep. 2024)

View and export this data going back to . Start your Free Trial

What is Kaya Holdings Debt-to-Asset?

Kaya Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was $0.23 Mil. Kaya Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was $8.84 Mil. Kaya Holdings's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Sep. 2024 was $0.27 Mil. Kaya Holdings's debt to asset for the quarter that ended in Sep. 2024 was 33.70.

Kaya Holdings Debt-to-Asset Historical Data

The historical data trend for Kaya Holdings's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kaya Holdings Debt-to-Asset Chart

Kaya Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Asset

Get a 7-Day Free Trial

2.48

3.24

4.78

9.34

38.62

Kaya Holdings Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Debt-to-Asset	Get a 7-Day Free Trial															35.08	38.62	36.99	29.08	33.70

Competitive Comparison of Kaya Holdings's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Kaya Holdings's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kaya Holdings's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kaya Holdings's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Kaya Holdings's Debt-to-Asset falls into.

Kaya Holdings Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Kaya Holdings's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0.28	+	8.061)	/	0.216
	=	38.62

Kaya Holdings's Debt-to-Asset for the quarter that ended in Sep. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0.227	+	8.839)	/	0.269
	=	33.70

Kaya Holdings (OTCPK:KAYS) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Kaya Holdings Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Kaya Holdings's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Kaya Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kaya Holdings Inc (OTCPK:KAYS) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

915 Middle River Drive, Suite 316, Fort Lauderdale, FL, USA, 33304

Website

https://www.kayaholdings.com

Kaya Holdings Inc is a holding company. It is focusing on wellness and mental health through operations in psychedelic treatment clinics, medical and recreational cannabis, and CBD products. The company own and operate a medical cannabis dispensary in the United States. Its has produced, distributed, and/or sold a full range of premium cannabis products including flower, oils, vape cartridges and cannabis infused confections, baked goods and beverages through a fully integrated group of subsidiaries and companies supporting highly distinctive brands.